Artal Group S.A. - PREVAIL THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$3,082,000
-44.1%
302,750
-18.2%
0.08%
-51.3%
Q2 2020$5,513,000
+126.1%
370,000
+85.0%
0.15%
+49.5%
Q1 2020$2,438,000200,0000.10%
Other shareholders
PREVAIL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 13,822,463$140,713,0001.77%
Omega Fund Management, LLC 187,538$1,909,0000.52%
Boxer Capital, LLC 1,123,105$11,433,0000.40%
RA Capital Management 1,915,568$19,500,0000.36%
DAFNA Capital Management LLC 75,000$764,0000.25%
QVT Financial LP 133,690$1,361,0000.17%
Woodline Partners LP 385,480$3,924,0000.13%
Virtus ETF Advisers LLC 19,773$201,0000.10%
WEXFORD CAPITAL LP 37,963$386,0000.10%
GSA CAPITAL PARTNERS LLP 53,018$540,0000.09%
View complete list of PREVAIL THERAPEUTICS INC shareholders